These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19169332

  • 1. False-negative apraclonidine testing in acute Horner syndrome.
    Dewan MA, Harrison AR, Lee MS.
    Can J Ophthalmol; 2009 Feb; 44(1):109-10. PubMed ID: 19169332
    [No Abstract] [Full Text] [Related]

  • 2. Possible effect of systemic sympathicolytic drugs on apraclonidine test.
    Martín-Moro JG, Botín DM, Muñoz-Negrete FJ.
    Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173
    [No Abstract] [Full Text] [Related]

  • 3. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A, Borruat FX.
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [Abstract] [Full Text] [Related]

  • 4. But it's not all there.
    Peterson JD, Bilyk JR, Sergott RC.
    Surv Ophthalmol; 2013 May; 58(5):492-9. PubMed ID: 22784676
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M, Seror J, Debroucker T.
    J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P, Satterfield D, Lim MK.
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [Abstract] [Full Text] [Related]

  • 14. Using apraclonidine in diagnosing Horner syndrome in children.
    Sueke H, Chandna A.
    Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL.
    Ophthalmic Plast Reconstr Surg; 2006 May; 22(1):53-5. PubMed ID: 16418668
    [Abstract] [Full Text] [Related]

  • 17. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM.
    Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244
    [No Abstract] [Full Text] [Related]

  • 18. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB, Farahvash A, Zhang A, Micieli JA.
    J Neurol Sci; 2020 Dec 15; 419():117190. PubMed ID: 33075593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E.
    Br J Ophthalmol; 2005 Nov 15; 89(11):1442-4. PubMed ID: 16234449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.